Quarterly Results

  • Company Name :
Jubilant Pharmova Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 530019
  • NSE Symbol:
  • JUBLPHARMA
  • P/E(TTM):
  • -
  • ISIN Demat:
  • INE700A01033
  • Div & Yield%:
  • 0.42
  • EPS(TTM):
  • 1.54
  • Book Value(₹):
  • 145.52
  • Market Cap(₹Cr.):
  • 19,060.25
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 215.30 193.40 162.60
Excise Duty 0.00 0.00 0.00
Net Sales 215.30 193.40 162.60
Other Operating Income 2.00 2.60 3.10
Other Income 17.90 18.40 43.80
Total Income 235.20 214.40 209.50
Total Expenditure 191.30 185.00 171.80
PBIDT 43.90 29.40 37.70
Interest 7.00 7.40 7.80
PBDT 36.90 22.00 29.90
Depreciation 13.40 13.30 13.30
Tax 8.20 6.30 5.30
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 1.70 -2.90 0.80
Reported Profit After Tax 13.60 5.30 10.50
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 13.60 5.30 10.50
EPS (Unit Curr.) 0.86 0.33 0.66
EPS (Adj) (Unit Curr.) 0.86 0.33 0.66
Calculated EPS (Unit Curr.) 0.86 0.33 0.66
Calculated EPS (Adj) (Unit Curr.) 0.86 0.33 0.66
Calculated EPS (Ann.) (Unit Curr.) 3.42 1.33 2.64
Calculated EPS (Adj) (Ann.) (Unit Curr.) 3.42 1.33 2.64
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 15.90 15.90 15.90
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 20.39 15.20 23.19
PBDTM(%) 17.14 11.38 18.39
PATM(%) 6.32 2.74 6.46